Oxycodone and Takhzyro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxycodone (oxycodone hydrochloride) and Takhzyro (lanadelumab-flyo). Common drug interactions include hereditary angioedema among females and hereditary angioedema among males.

The phase IV clinical study analyzes what interactions people have when they take Oxycodone and Takhzyro. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

What is Takhzyro?

Takhzyro has active ingredients of lanadelumab-flyo. eHealthMe is studying from 2,828 Takhzyro users. Check the latest studies of Takhzyro.

On Jul, 16, 2026

38 people who take Oxycodone and Takhzyro together, and have interactions are studied.

Oxycodone and Takhzyro drug interactions.

What are the common drug interactions of Oxycodone and Takhzyro, by gender? *:

female:

Hereditary angioedema (recurrent episodes of severe swelling)
Drug ineffective
Gastric haemorrhage (bleeding stomach)
Laryngeal oedema (swelling of larynx)
Stress
Tooth infection
Asthenia (weakness)
Dizziness
Fatigue (feeling of tiredness)
Headache (pain in head)

male:

Hereditary angioedema (recurrent episodes of severe swelling)
Hepatic fibrosis (scarring process that represents the liver's response to injury)
Adverse drug reaction
Pneumonia
Injection site discharge
Injection site pain
Lung carcinoma cell type unspecified stage iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver)
Rhinorrhoea (watery mucus discharge from the nose)
Pulmonary thrombosis (scarring in the lungs)
Prostatomegaly (enlargement of the prostate)

What are the common drug interactions of Oxycodone and Takhzyro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Hereditary angioedema (recurrent episodes of severe swelling)
Laryngeal oedema (swelling of larynx)
Stress
Tooth infection
Temperature intolerance (inability to go in temperature)

30-39:

n/a

40-49:

n/a

50-59:

Hepatic fibrosis (scarring process that represents the liver's response to injury)
Hereditary angioedema (recurrent episodes of severe swelling)
Pulmonary thrombosis (scarring in the lungs)
Prostatomegaly (enlargement of the prostate)
Urinary tract infection
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)

60+:

Asthenia (weakness)
Dizziness
Pruritus (severe itching of the skin)
Drug ineffective
Fatigue (feeling of tiredness)
Gastric haemorrhage (bleeding stomach)
Headache (pain in head)
Hereditary angioedema (recurrent episodes of severe swelling)
Thrombosis (formation of a blood clot inside a blood vessel)
Vision blurred

What are the existing conditions these people have? *

Hereditary Angioedema (recurrent episodes of severe swelling): 26 people, 68.42%
Immune System Disorder: 15 people, 39.47%
Nausea (feeling of having an urge to vomit): 9 people, 23.68%
Hyperemesis Gravidarum (a condition characterized by severe nausea, vomiting, weight loss, and electrolyte disturbance): 5 people, 13.16%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone and Takhzyro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously